Ahrens Investment Partners’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
CS
Ahrens Investment Partners's GH Position: Q1 2022 in Review
Ahrens Investment Partners sold out of Guardant Health (GH) in Q1 2022, closing a stake of 100 shares — an estimated $10K sold.
Ahrens Investment Partners first reported a position in GH in Q4 2021 and held it in 1 quarter. The position peaked at $10K in Q4 2021. 355 funds tracked by Wall St. Rank hold GH as of Q1 2022.
- Ahrens Investment Partners reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
- Ahrens Investment Partners sold 100 Guardant Health shares in Q1 2022, an estimated $10K.
- Ahrens Investment Partners first reported a position in Guardant Health in Q4 2021 and held it in 1 quarter.
- Ahrens Investment Partners's Guardant Health position peaked at $10K in Q4 2021.
- 355 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.
Based on Ahrens Investment Partners's 13F filing for Q1 2022, filed 28 Apr 2022.